Enfoques para Identificar Personas con Hemofilia con Datos de Reclamaciones de Medicare

Stacey A Fedewa1,2, Tyler W Buckner3, Lorraine Cafuir1,2

  • 1Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.

Resumen

Al comparar tres métodos para identificar personas con hemofilia A (PHAs) en reclamaciones de Medicare, este estudio encontró que los códigos de diagnóstico por sí solos pueden contar en exceso los casos, mientras que los algoritmos y los datos de tratamiento pueden subrepresentar a pacientes no graves o mujeres. Se necesitan algoritmos validados para una mejor investigación de la hemofilia.

Videos de Conceptos Relacionados

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Pedigree Analysis01:35

Pedigree Analysis

Overview
88.7K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
530